Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Niara Oliveira

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Current Treatment Options in Oncology|June 24, 2024
Metastatic Castration-Resistant Prostate Cancer: Advances in Treatment and Symptom ManagementTivya Kulasegaran, Niara Oliveira
Asia-Pacific Journal of Clinical Oncology|September 2, 2025
Factors Affecting Quality Control (QC) Failure Rates in Somatic Breast Cancer (BRCA) Gene Testing in Castrate Resistant Prostate Cancer: Experiences From an Australian Cancer Care CentreCian O'Leary, Edward Yoong, Admire Matsika, et al.
Asia-Pacific Journal of Clinical Oncology|August 23, 2019
Cancer in PregnancyNaomi Eastwood-Wilshere, Jessica Turner, Niara Oliveira, et al.
BMJ Case Reports|August 7, 2019
Metastatic uterine leiomyosarcoma at 26 weeks gestationNaomi Eastwood-Wilshere, Jessica Turner, Niara Oliveira, et al.
Asia-Pacific Journal of Clinical Oncology|September 20, 2023
Systemic treatment of advanced and metastatic urothelial cancer: The landscape in AustraliaHoward Gurney, Timothy D Clay, Niara Oliveira, et al.
BMC Ophthalmology|February 26, 2014
Toxic optic neuropathy in the setting of docetaxel chemotherapy: a case reportThomas P Moloney, Wen Xu, Kristopher Rallah-Baker, et al.
BMJ Supportive & Palliative Care|December 18, 2025
Genomic variation in symptom expression in castrate-resistant prostate cancerJanet Hardy, Ristan Greer, Karyn Foster, et al.
Future Oncology (London, England)|July 29, 2025
SGNDV-001: disitamab vedotin with pembrolizumab in HER2-expressing locally advanced or metastatic urothelial carcinomaThomas B Powles, Enrique Grande, Nimira Alimohamed, et al.
The New England Journal of Medicine|September 16, 2024
Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder CancerThomas Powles, James W F Catto, Matthew D Galsky, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Current Treatment Options in Oncology|June 24, 2024
Metastatic Castration-Resistant Prostate Cancer: Advances in Treatment and Symptom ManagementTivya Kulasegaran, Niara Oliveira
Asia-Pacific Journal of Clinical Oncology|September 2, 2025
Factors Affecting Quality Control (QC) Failure Rates in Somatic Breast Cancer (BRCA) Gene Testing in Castrate Resistant Prostate Cancer: Experiences From an Australian Cancer Care CentreCian O'Leary, Edward Yoong, Admire Matsika, et al.
Asia-Pacific Journal of Clinical Oncology|August 23, 2019
Cancer in PregnancyNaomi Eastwood-Wilshere, Jessica Turner, Niara Oliveira, et al.
BMJ Case Reports|August 7, 2019
Metastatic uterine leiomyosarcoma at 26 weeks gestationNaomi Eastwood-Wilshere, Jessica Turner, Niara Oliveira, et al.
Asia-Pacific Journal of Clinical Oncology|September 20, 2023
Systemic treatment of advanced and metastatic urothelial cancer: The landscape in AustraliaHoward Gurney, Timothy D Clay, Niara Oliveira, et al.
BMC Ophthalmology|February 26, 2014
Toxic optic neuropathy in the setting of docetaxel chemotherapy: a case reportThomas P Moloney, Wen Xu, Kristopher Rallah-Baker, et al.
BMJ Supportive & Palliative Care|December 18, 2025
Genomic variation in symptom expression in castrate-resistant prostate cancerJanet Hardy, Ristan Greer, Karyn Foster, et al.
Future Oncology (London, England)|July 29, 2025
SGNDV-001: disitamab vedotin with pembrolizumab in HER2-expressing locally advanced or metastatic urothelial carcinomaThomas B Powles, Enrique Grande, Nimira Alimohamed, et al.
The New England Journal of Medicine|September 16, 2024
Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder CancerThomas Powles, James W F Catto, Matthew D Galsky, et al.
Pageof 1